Patent ID: 11951166
Assignee: BAYER AKTIENGESELLSCHAFT
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 22:
23. A medicament comprising the combination of claim 14 wherein component a) comprising regorafenib or its hydrate, solvate, metabolite, pharmaceutically acceptable salt, or a polymorph thereof, additionally comprises pharmaceutically acceptable ingredients selected from the group consisting of diluents, carriers, surfactants, fillers, disintegrants, recrystallization inhibitors, plasticizers, defoamers, antioxidants, detackifiers, pH-modifiers, glidants, acidifying agents, alkalinizing agents, adsorbents, antifungal preservatives, antimicrobial preservatives, binding materials, chelating agents, colorants, clarifying agents, emulsifying agents, encapsulating agents, flavorants, humectants, levigating agents, oils, ointment bases, penetration enhancers for transdermal delivery, solvents, stiffening agents, suppository bases, suspending agents, sweetening agents, tablet anti-adherents, tablet coating agents, tablet direct compression excipients, tablet/capsule opaquants, tablet polishing agents, viscosity increasing agents, and wetting agents and lubricants.